Infarmed approves marketing of three cannabis products

Infarmed approves marketing of three cannabis products

Infarmed has authorized the sale of three new medicinal cannabis preparations, bringing the total to four products available in Portugal, as announced to Lusa. Previously, only one preparation with 18% THC and less than 1% CBD had been on the market since 2021. Read more here

If you need more information about medical cannabis regulatory services in the pharmaceutical and healthcare industries, ELS can certainly help.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.